In this week’s full length podcast, I dive into the viewer question box and pull out some interesting topics. The first is how CRO’s and Sponsors ensure that PI’s are truly reading the Serious Adverse Event Reports that they send to all research sites, or whether they are just signing and filing. The next question is how to tell the difference between a CRO and an SMO in clinical research. Another topic is PI availability versus the Sponsor’s ever increasing demands for more PI oversight and what we can expect in 2014 and 2015 in this industry. There are other topics I cover here as well and I hope you find some value out of it.
Self-explanatory topic that is also somewhat related to this video as they both are themed around the less-talked about issues in clinical research.
Something that I recently learned from a medical monitor at a large pharma company is the fact that they check the pk samples for study participants and keep track of which research sites have a disproportionate number of non-compliant study participants. This is important because it can keep you from actually getting future studies from these Sponsors!
The title is self-explanatory but it is derived from a question I received on Twitter regarding this article.
As with anything on the internet, my own content included, NEVER believe everything you hear, read, see, etc. With that being said, I discovered from several credible sources in the CRO and Pharma space, a very rough ballpark figure in regards to salaries for CRA’s, Project Managers, and Medical Monitors. If you have heard anything different, send me an email.
Just thought it was something I need to share. If you think follow up is not important, think again. Be persistent when it comes to your phone calls and emails and you should eventually get a response.